NCT03508258

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Investigating the Association of Type of Anticoagulation Treatment for Non-valvular Atrial Fibrillation and Risk of Bleeding in England

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Bristol-Myers Squibb · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study of patients with nonvalvular atrial fibrillation (NVAF) who are newly prescribed NOACs (Novel Oral Anticoagulants) in routine clinical practice in England

Conditions

• Non-valvular Atrial Fibrillation

Interventions

Type	Name	Description
OTHER	Non-interventional	Non-interventional
OTHER	Non-Interventional	Non-Interventional

Timeline

• Start date: 2017-09-01
• Primary completion: 2018-09-01
• Completion: 2018-09-01
• First posted: 2018-04-25
• Last updated: 2022-06-30

Locations

1 site across 1 country: United States